EMN Secures Series A Funding to Transform Surgical Nutrition
Enhanced Medical Nutrition, Inc. (EMN), a pioneering company in the food-as-medicine sector, has successfully raised
$5 million in a Series A funding round that was oversubscribed. Leading the financing are
dsm-firmenich Venturing and the Corporate Venture Capital (CVC) of Ajinomoto Co., Inc. Additionally, the funding round saw participation from PeakBridge, Elder Ventures, and various angel investors and existing shareholders. This capital infusion is set to facilitate the expansion of their
ENROUTE® program, which focuses on the nutritional management of surgical patients.
Surgery is a critical time for patients, and ensuring proper nutrition is essential for improving outcomes. EMN recognizes this significant gap in tailored nutritional support for surgical patients. Eric Zimmerman, CEO and Co-Founder of EMN, emphasized how essential nutrition is for surgical success and outlined the company's mission to establish a new standard of care in surgical practices. He noted, "Nutrition is widely recognized as a critical factor in improving surgical outcomes, yet there remains a significant gap in solutions tailored specifically to patients' needs."
The ENROUTE® program aims to address the nutritional requirements of patients before and after surgical procedures, thereby reducing health risks and enhancing recovery. This innovative program is poised to disrupt the status quo where nutrition is frequently overlooked in surgical protocols. By applying a technology-driven approach to nutritional care, EMN aims to significantly enhance patient experiences and outcomes.
Investment Director at dsm-firmenich Venturing, Arpesh Mehta, expressed optimism about EMN’s potential impact on surgical care. He highlighted the company's commitment to scientific validation and innovation centered around patient needs. He remarked, "The company's dedication to scientific validation and patient-centric innovation aligns with our vision of leveraging functional ingredients and empowering market-ready solutions that improve human health."
Ajinomoto, another key investor, is particularly interested in the benefits of nutritional supplementation throughout the surgical process—beginning from prehabilitation and continuing through rehabilitation. Shunji Takehana, Senior Vice President at Ajinomoto, noted that this investment symbolizes the start of a strategic partnership aimed at improving surgical care through nutrition.
PeakBridge’s Gali Artzi stated, "This investment reflects PeakBridge's commitment to supporting innovative solutions in the food-as-medicine space. EMN's approach offers an essential innovation to an underserved market, promising improvements in healthcare nutrition and patient outcomes."
About Enhanced Medical Nutrition (EMN)
Based in Toronto and Chicago, EMN is establishing itself as a transformative force in the food-as-medicine world. The company’s flagship product,
ENROUTE®, is specifically designed to meet the unique nutritional needs of surgical patients, promoting safer procedures and quicker recoveries. The approach is not only focused on physical recovery but also aims to enhance overall patient experience during a tumultuous time.
About ENROUTE®
ENROUTE® is a proprietary nutrition program grounded in rigorous research and clinical evidence. It is targeted at adult patients prepping for surgery, particularly in orthopedic fields, to meet their specific metabolic needs. The program provides critical nutrients that support healing processes, muscle maintenance, and immune response during recovery.
In a world where health care is continuously evolving, EMN proudly champions the integration of nutrition into patient care, thereby redefining what comprises optimal surgical preparation and recovery. The company highlights that food can be a powerful ally in fighting health challenges and improving the quality of life, effectively making it a crucial aspect of modern medical care.
For further information about their innovative offerings, visit
www.getenroute.com.